Iain S McGregor Selected Research

Iain S McGregor Research Topics

Disease

14	Epilepsy (Aura) 06/2022 - 01/2016
12	Hypothermia 01/2022 - 08/2003
11	Seizures (Absence Seizure) 01/2022 - 01/2013
7	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2022 - 11/2019
7	Schizophrenia (Dementia Praecox) 01/2017 - 08/2010
7	Body Weight (Weight, Body) 05/2014 - 04/2004
7	Hyperthermia 08/2009 - 06/2002
6	Substance-Related Disorders (Drug Abuse) 05/2022 - 10/2010
5	Pica (Geophagia) 02/2019 - 01/2017
4	Chronic Pain 10/2021 - 01/2019
4	Anxiety Disorders (Anxiety Disorder) 09/2021 - 11/2005
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018 - 03/2012
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2020
3	Pain (Aches) 01/2022 - 12/2014
3	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 11/2019 - 08/2014
3	Infections 11/2019 - 02/2004
3	Marijuana Abuse (Cannabis Abuse) 01/2018 - 01/2013
3	Bradycardia 10/2017 - 09/2015
3	Alcoholism (Alcohol Abuse) 05/2017 - 09/2004
3	Mental Disorders (Mental Disorder) 10/2016 - 03/2013
2	Psychotic Disorders (Schizoaffective Disorder) 05/2022 - 01/2019
2	Sleep Wake Disorders 01/2022 - 10/2020
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 10/2020
2	Cancer Pain 10/2021 - 01/2018
2	Catalepsy 01/2020 - 08/2010
2	Inflammation (Inflammations) 12/2019 - 09/2013
2	Cardiotoxicity 01/2019 - 01/2018
2	Anorexia Nervosa 01/2019 - 01/2018
2	Multiple Sclerosis 01/2019 - 03/2014
2	Memory Disorders (Memory Loss) 01/2017 - 04/2008
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2014 - 01/2013
2	Meningitis 08/2014 - 08/2014
2	Drug Fever 01/2007 - 08/2003
2	Long Term Adverse Effects 08/2005 - 04/2004
1	Necrosis 03/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

18	CannabinoidsIBA 01/2022 - 06/2004
15	Pharmaceutical PreparationsIBA 06/2022 - 08/2003
11	CannabidiolIBA 06/2022 - 08/2010
11	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 11/2007
11	Dronabinol (THC)FDA LinkGeneric 10/2021 - 04/2008
9	Oxytocin (Pitocin)FDA LinkGeneric 01/2018 - 10/2010
9	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 08/2009 - 06/2002
8	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2006
6	Medical MarijuanaIBA 01/2022 - 01/2017
5	Serotonin (5 Hydroxytryptamine)IBA 09/2013 - 08/2003
4	Methamphetamine (Desoxyn)FDA LinkGeneric 05/2022 - 08/2005
4	Anti-Anxiety Agents (Anxiolytics)IBA 09/2021 - 11/2007
4	NeuropeptidesIBA 05/2017 - 10/2010
4	Neuregulin-1 (Neuregulin 1)IBA 01/2017 - 06/2011
3	EndocannabinoidsIBA 01/2022 - 06/2011
3	Clobazam (HR 376)IBA 12/2021 - 11/2019
3	EnzymesIBA 09/2021 - 02/2004
3	SolutionsIBA 01/2020 - 01/2013
3	RimonabantIBA 01/2020 - 06/2004
3	5F-CUMYL-PICAIBA 01/2019 - 01/2017
3	Antidepressive Agents (Antidepressants)IBA 10/2014 - 11/2007
2	cannabigerolic acidIBA 01/2022 - 12/2021
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022 - 01/2022
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2022 - 08/2010
2	Illicit Drugs (Recreational Drugs)IBA 01/2022 - 08/2009
2	Aminobutyrates (Aminobutyric Acid)IBA 01/2020 - 12/2019
2	cumyl-PINACAIBA 02/2019 - 10/2017
2	indoleIBA 01/2019 - 01/2017
2	methyl 2- (1- (4- fluorobenzyl)- 1H- indazole- 3- carboxamido)- 3- methylbutanoateIBA 01/2019 - 01/2018
2	Cannabinoid Receptor AgonistsIBA 01/2018 - 06/2011
2	nabiximols (Sativex)IBA 01/2018 - 03/2014
2	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- pentyl- 1H- indazole- 3- carboxamideIBA 01/2017 - 09/2015
2	AB-FUBINACAIBA 01/2017 - 09/2015
2	Tryptophan (L-Tryptophan)FDA Link 10/2016 - 08/2014
2	Ethanol (Ethyl Alcohol)IBA 03/2015 - 03/2012
2	Antipsychotic Agents (Antipsychotics)IBA 10/2014 - 01/2013
2	Methylphenidate (Ritalin)FDA LinkGeneric 10/2014 - 01/2013
2	CytokinesIBA 08/2014 - 02/2004
2	Sucrose (Saccharose)IBA 05/2014 - 01/2013
1	Terpenes (Terpenoids)IBA 06/2022
1	SodiumIBA 06/2022
1	InterleukinsIBA 03/2022
1	LipopolysaccharidesIBA 03/2022
1	MyoglobinIBA 03/2022
1	olivetolic acidIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	EstersIBA 01/2022
1	SolventsIBA 01/2022
1	MercuryIBA 01/2022
1	ArsenicIBA 01/2022
1	Heavy MetalsIBA 01/2022
1	CannabinolIBA 01/2022
1	CadmiumIBA 01/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	Escitalopram FDA Link 09/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2021
1	Citalopram FDA LinkGeneric 09/2021
1	Therapeutic UsesIBA 03/2021
1	OilsIBA 01/2021

Therapy/Procedure

6	Induced Hyperthermia (Thermotherapy) 01/2022 - 06/2004
3	Therapeutics 01/2021 - 11/2019
2	Drug Therapy (Chemotherapy) 01/2019 - 09/2004
2	Induced Hypothermia 10/2017 - 09/2015